Abstract: The present invention relates to the production of steviol glycoside rebaudiosides D4, WB1 and WB2 and the production of rebaudioside M from Reb D4.

Abstract: A method for preparing cassava flour with a low content of cyanogenic glycosides is provided. The method includes: washing, peeling, and cutting newly harvested fresh cassava to obtain cassava pellets, cassava shreds, or a cassava pulp as a raw material. The method further includes the following steps: immersing the raw material in a solution containing cellulase and pectinase for 10-30 minutes, and then placing the raw material in warm water with a temperature of 35-50° C. and a pH value of 5.5-6.5 and ultrasonicating for 10-30 minutes at an ultrasonic frequency of 50-80 kHz, to obtain an ultrasonicated raw material; drying and pulverizing the ultrasonicated raw material to obtain cassava flour with a low content of cyanogenic glycosides, a cyanogenic glycoside content of the cassava flour is less than 15 mg/kg.

Abstract: Disclosed are an intermediate drug having synergistic anticancer activity and a polyethylene glycol-coupled synergistic anticancer drug, and a method preparing therefor and use thereof. The intermediate drug has the general structural formula of (I), and the polyethylene glycol-coupled synergistic anticancer drug has the general structural formula of (II). The drugs achieve the combined medication of various anticancer drugs and avoid the toxic reaction caused by the interaction among the drugs or by the pharmacokinetics of the drugs when taking various anticancer drugs, facilitate overcoming the multidrug resistance of cancers, have a synergistic effect, and can be used for preparing anticancer medicaments and for treating cancers.

Abstract: A method for preparing cassava flour with a low content of cyanogenic glycosides is provided. The method includes: washing, peeling, and cutting newly harvested fresh cassava to obtain cassava pellets, cassava shreds, or a cassava pulp as a raw material. The method further includes the following steps: immersing the raw material in a solution containing cellulase and pectinase for 10-30 minutes, and then placing the raw material in warm water with a temperature of 35-50° C. and a pH value of 5.5-6.5 and ultrasonicating for 10-30 minutes at an ultrasonic frequency of 50-80 kHz, to obtain an ultrasonicated raw material; drying and pulverizing the ultrasonicated raw material to obtain cassava flour with a low content of cyanogenic glycosides, a cyanogenic glycoside content of the cassava flour is less than 15 mg/kg.

Abstract: Disclosed is a nursing bed-chair assembly, which includes a nursing bed and a wheelchair. The nursing bed includes a bed frame, and a connecting mechanism and an interfacing mechanism which are mounted on the bed frame. The butt-joint mechanism includes a guide rail, a butt-joint fixing plate and butt-joint members. The guide rail is mounted on the bed frame, the butt-joint fixing plate is slidably mounted on the guide rail, and the butt-joint members are mounted on the butt-joint fixing plate. The wheelchair includes a wheelchair frame, a backrest and a seat plate which are mounted on the wheelchair frame, main wheels rotatablely mounted on both sides of the wheelchair frame, armrests, and butt-joint portions in butt joint with the butt-joint members.

Abstract: Disclosed are an intermediate drug having synergistic anticancer activity and a polyethylene glycol-coupled synergistic anticancer drug, and a method preparing therefor and use thereof. The intermediate drug has the general structural formula of (I), and the polyethylene glycol-coupled synergistic anticancer drug has the general structural formula of (II). The drugs achieve the combined medication of various anticancer drugs and avoid the toxic reaction caused by the interaction among the drugs or by the pharmacokinetics of the drugs when taking various anticancer drugs, facilitate overcoming the multidrug resistance of cancers, have a synergistic effect, and can be used for preparing anticancer medicaments and for treating cancers.

Abstract: The present invention has disclosed a wind power bundling control method after wind power and thermal power are connected to a power grid in the field of electric power system security technology, including regulating wind power output and thermal power output forward or backward; calculating the transient stability margin of the grid, load level index of element and voltage out-of-limit index of busbar after regulating wind power output and thermal power output respectively; calculating wind power/thermal power paying value according to the transient stability margin of the grid, load level index of element and voltage out-of-limit index of busbar after regulating wind power output and thermal power output; if wind power/thermal power paying value is larger than set threshold value, regulating wind power output and thermal power output backward/forward; if wind power/thermal power paying value is smaller than set threshold value, regulating wind power output and thermal power output forward/backward.

Abstract: The present invention has disclosed a wind power bundling control method after wind power and thermal power are connected to a power grid in the field of electric power system security technology, including regulating wind power output and thermal power output forward or backward; calculating the transient stability margin of the grid, load level index of element and voltage out-of-limit index of busbar after regulating wind power output and thermal power output respectively; calculating wind power/thermal power paying value according to the transient stability margin of the grid, load level index of element and voltage out-of-limit index of busbar after regulating wind power output and thermal power output; if wind power/thermal power paying value is larger than set threshold value, regulating wind power output and thermal power output backward/forward; if wind power/thermal power paying value is smaller than set threshold value, regulating wind power output and thermal power output forward/backward.

Abstract: Electronic packaging arrangements having lead-free solders are disclosed. In particular, lead-free solder compositions and lead frame constructs for use therewith are disclosed. The lead-free solder compositions may be zinc-based and may include zinc, aluminum, and germanium as major components and gallium and magnesium as minor components. The lead-free, zinc-based solder compositions may exhibit desirable melting properties, mechanical properties, and wetting properties, for example.